Skip to content
naulon
Get started

No retraction, correction or concern found when last checked on Oct 27, 2026.

Updates on Aptamer Research

Mohamed H. Ali, Marwa E. Elsherbiny, Marwan Emara

International Journal of Molecular Sciences · 2019 · Review · CC BY

doi:10.3390/ijms20102511

Abstract

For many years, different probing techniques have mainly relied on antibodies for molecular recognition. However, with the discovery of aptamers, this has changed. The science community is currently considering using aptamers in molecular targeting studies because of the many potential advantages they have over traditional antibodies. Some of these possible advantages are their specificity, higher binding affinity, better target discrimination, minimized batch-to-batch variation, and reduced side effects. Overall, these characteristics of aptamers have attracted scholars to use them as molecular probes in place of antibodies, with some aptamer-based targeting products being now available in the market. The present review is aimed at discussing the potential of aptamers as probes in molecular biology and in super-resolution microscopy.

Full text

From PubMed Central, U.S. National Library of Medicine, as current on Oct 27, 2026. Paragraph numbers are ours, so an answer can point at one.

1. Introduction

Nucleic acids (NAs) were for a long time considered compounds whose major functions were related to the storage of inherited information (DNA) and its transfer from gene to protein through RNA. However, studies have over time confirmed that NAs perform other functions such as enzymatic catalysis and the regulation of transcription. The discovery of these additional functions of NAs has compelled the scholarly community to reconsider its original position concerning the functions of NAs. Consequently, this change has led the scientific community to propose the “RNA world theory”. In particular, this theory posits that NAs possess the ability to perform multiple functions and have presumably facilitated all the catalytic reactions that started life on earth. The discovery of aptamers is indeed a valuable contribution towards the empirical determination of the multifunctional nature of NAs. Essentially, aptamers are small, often ranging between 20 to 60 nucleotides, single-stranded DNA or RNA oligonucleotides that are capable of binding target molecules not only with high specificity but also with high affinity.

Aptamers, the output of systematic evolution of ligands by exponential enrichment (SELEX) process, have been available for about three decades. In particular, the development of aptamers is attributed to the work of Craig Tuerk and Larry Gold in 1990. Gold and Tuerk focused on investigating the nature of the “translational operator” within the bacteriophage T4 gene 43 mRNA. This research led to performing the first SELEX experiment that produced two winning hairpins, the wild-type T4 sequence as well as another containing quadruple mutations, both bound to the gene 43 protein with the same affinities. Although, Tuerk’s experiments pioneered the SELEX process, the process was not named SELEX until Szostak and Ellington developed the same method and coined the term SELEX. The term refers to a process that entails progressive separation of single-stranded DNAs or RNAs (ssDNA/RNA) combinatorial single-stranded oligonucleotide library via repeated rounds of binding, partitioning, and amplification. It is noted that following the development of this novel technology, different modified SELEX techniques have emerged over the past three decades. Table 1 summarizes the different SELEX methods, as described in their original context. Some of these developments tackled the ssDNA/RNA library improvement, while many others addressed the development of the SELEX process. In the contemporary research environment, cell-SELEX (illustrated in Figure 1) has been extensively used to identify and select aptamers that can help in the diagnosis as well as the development of treatments for different diseases, particularly for cancer. Thus, cell-SELEX technology has become increasingly important in medical research.

Currently, a significant number of generated aptamers are indeed capable of binding different targets, including large protein complexes, simple inorganic molecules, and whole cells. From this prospective, aptamers are simply considered nucleotide analogues of antibodies. However, compared to antibodies, the generation of aptamers is significantly easier and cheaper. Thus if appropriately developed, these characteristics make aptamers ideal candidates for a wide variety of applications such as disease diagnosis, biosensor design, nanotherapy, molecular imaging, and the purification of particular target molecules from complex mixtures.

The science community has in the recent years developed super-resolution imaging techniques that offer three-dimensional imaging capabilities that overcome the diffraction restrictions of conventional light microscopy especially in viewing lateral dimensions. For example, techniques such as single-molecule localization or stimulated emission depletion microscopy (STED) and secondary ion mass spectrometry microscopy have enabled scientists to visualize whether objects are in fact localized. However, the advancement of these techniques requires additional improvements in the fluorescent labels to harness the power of super resolution as the image resolution is also restricted by the effectiveness of the labelling probes’ size, specificity, stability, and density. Indeed, the development of these novel techniques has encouraged researchers to reconsider labelling in super resolution. Aptamers’ favourable characteristics have attracted scientists to consider using them in place of antibodies in super resolution. The focus of this review is to demonstrate the potential of aptamers as probing tools that can be used in super resolution.

2. Antibodies and Aptamers

Antibodies, as pointed out in the preceding section, are a popular class of compounds that have long been used in research to provide molecular identification for a broad array of applications, including disease diagnosis and therapy. Consequently, antibodies have made significant contributions towards the improvement of diagnostic assays. In fact, it can be argued that antibodies have become increasingly indispensable in most of the clinical diagnostic tests in the modern medicine. However, the emergence of SELEX (outlined in Table 1) has made it possible for researchers to progressively isolate oligonucleotide sequences capable of recognizing nearly any class of target molecules not only with high affinity but with high specificity as well. Although completely distinct from antibodies, aptamers are thought to emerge as a class of compounds that rival antibodies in terms of both diagnostic and therapeutic applications. Indeed, the available body of knowledge has confirmed that this class of molecules mimics the properties of antibodies in several formats. Mairal et al. contended that the high demand for diagnostic assays that can effectively help in the management of present and emerging diseases has soared in recent years and it is suggested that aptamers could potentially satisfy various molecular recognition needs in these diagnostic assays. Although the research on aptamers is still in its infancy, there is compelling evidence that this field of research is progressing at a fast pace.

The discovery of aptamers has already helped circumvent some of the key limitations associated with antibodies. A critical evaluation of the present body of knowledge on antibodies and aptamers shows that these classes both have advantages and disadvantages (summarized in Table 2) over each other with multiple pieces of empirical evidence reveal that aptamers provide a broad array of clear-cut merits over conventional antibodies.

Some of the key advantages of aptamers include their inertness towards the surrounding cells. Specific aptamers are capable of binding to a target molecule with high precision and, thus, it is thought that this can facilitate a broad array of diagnostic and therapeutic applications without the fear of potential non-specific binding. Another advantage is that they often have a higher binding affinity. It is indeed acknowledged that in cases where several ligands can bind to the same receptor site, aptamers have been found to offer a relatively higher binding affinity. It is worth noting that, in practice, the higher the affinity level of a biological molecule used in molecular recognition, the less quantity is needed in molecular identification, which may reduce the costs of performing molecular identification studies.

Aptamers also often exhibit excellent target molecule specificity compared to antibodies. According to Kedzierski et al., there are aptamers that exhibit >10,000-fold binding affinity for theophylline over caffeine. There is no doubt that this excellent target specificity makes aptamers ideal bio-markers as they increase the accuracy of molecular recognition. Another advantage is that aptamers facilitate the discovery of unknown biomarkers. Kedzierski et al. explained that different SELEX techniques are capable of identifying unknown biomarkers and consequently, this has in the recent years hastened the discovery of diseases and therapeutics. Some other advantages of aptamers over the conventional antibodies include discovery time savings, minimized batch-to-batch variation, in vitro vs. in vivo testing advantages, increased stability, and reduced side effects.

It is worth noting that nanobodies, antibody-mimicking binders that are a single variable domain of an antibody, are also capable of specific binding and are also used in molecular targeting. Previous studies have suggested that the use of affinity probes such as aptamers and nanobodies has many advantages in light microscopy, particularly in the field of super resolution. De Castro et al. explained that steric hindrance causes less impairment on these small molecular probes and, thus, facilitates their penetration into biological samples and their binding to epitopes that are traditionally inaccessible to larger antibodies. Indeed, traditional light microscopy suffers from limited resolution capabilities due to light diffraction. Many methodologies that are capable of overcoming this limitation were developed in the recent years. In fact, it has been reported that diffraction-unlimited microscopes are improving rapidly and, as a result, it is now practical to attain excellent resolutions of small elements of less than 10 nm. Nevertheless, the enhancement of sample preparation and methodologies used in staining is still lagging behind. The conventional immunostaining technique largely depends on affinity tools that at times are larger than the protein of interest making it impossible to fully exploit the potential of contemporary imaging techniques. However, it is anticipated that small probes such as nanobodies and aptamers would have a significant impact on the precision of staining biological samples. Recent studies have in fact suggested that when compared to traditional antibody techniques, nanobodies are capable of positioning the fluorescent molecules closer to the intended target, and thereby resulting in enhanced localization precisions using super-resolution microscopy. Likewise, in a comparative study of aptamers vs. antibodies that involved STED, it was concluded that in super-resolution microscopy, aptamers offer superior staining of different cellular receptors. Since aptamers are cheap to select and nanobodies usually have higher affinities, it is thought that aptamers and nanobodies complement each other and together they should help advance the effectiveness of super-resolution imaging.

Although the use of aptamers as molecular identification compounds has emerged as a viable approach for diagnostics, therapeutics, and biosensing, aptamers do present a set of challenges that have inadvertently hampered both their research and commercialization. Firstly, relatively few aptamers bind small molecules. It is argued that small molecules are crucial targets for research because of their clinical and commercial uses as well as diverse biological functions. Therefore, the availability of relatively few aptamers binding to small molecules restricts research on their biological functions, clinical use, and commercial use. Secondly, aptamers are likely to encounter rapid clearance rate from the circulation because of their small size as well as degradation by nucleases especially for unmodified aptamers. Further, there are examples where developing a selective aptamer still represents a challenge. For example, aptamers that were selected against monomeric/oligomeric forms of amyloid peptide had very low affinity to these forms, although they exhibited a strong non-specific affinity to amyloid high-molecular weight fibrils. It is thought, however, that aptamers still hold promise for the treatment of Alzheimer’s disease because current amyloid inhibitors and antibodies are not effective at the membrane surface, where inhibition of amyloid aggregate and channel formation is needed to stop disease progression. Janas et al. 2019 shows that functional exosomes containing the selected pool of aptamers can inhibit the formation of amyloid aggregates and channel activity at the membrane surface.

Nevertheless, aptamer microarray technology has recently been developed in an effort to overcome the drawbacks and limitations of antibody microarrays, especially when targeting small molecules with one epitope. Indeed, aptamers that target small organics, peptides, proteins, viruses, cells, and bacteria are now commercially available from a number of emerging companies such as Aptagen and AMSBIO. Other companies have been established focusing on aptamers-based drug discovery such as OSI Pharmaceuticals, Nascacell Technologies in collaboration with Discovery Partners International, and Aptanomics. In addition, aptamer-based clinical trials are currently being run by different companies such as Baxter Biosciences, Corgentech, Bristol-Myers Squibb, Gilead Sciences, NOXXON Pharma, Oxford Cancer Research, Pfizer, and Regado Biosciences (reviewed in), while others are developing aptamer-based diagnostics or therapeutics including Aptamer Group, Base Pair Biotechnologies, and Ophthotech Corporation.

3. Super-Resolution Imaging

For many years, light microscopy has significantly improved the scientific understanding of how cells function. In fact, the different spheres of biology are believed to have developed from images that have been acquired under light microscopes. Nonetheless, studies that utilize conventional light microscopy techniques have been limited to the resolution of about 200 nm. The science community has for many years focused on developing several imaging techniques to address the diffraction of light. Some of these imaging techniques include multiphoton fluorescence microscopy and confocal microscopy. Fundamentally, these novel imaging techniques have not only significantly enhanced the resolution of cellular images, but have also reduced the out-of-focus fluorescence background. Consequently, this has facilitated optical sectioning and three-dimensional imaging. Although these techniques have significantly improved resolution, the approaches are still limited by light diffraction. In practice, these advanced techniques have often achieved resolutions of ~100 nm in all three dimensions.

Recently, this limitation in light microscopy has been overcome by many improved microscopy techniques, with some of the techniques achieving resolutions of ~10 nm. The capability of these novel advanced microscopy techniques to circumvent light diffraction has significantly improved imaging precision. Consequently, this has enabled researchers to identify important cellular details that could not be isolated using the traditional diffraction-limited instruments. STED, single-molecule localization techniques (SMLM), positron-emission tomography (PET), single-photon emission computed tomography (SPECT), and cryo-electron microscopy (cryo-EM) are some of the common diffraction-unlimited techniques that have made a significant impact in biological sciences. For example, stochastic optical reconstruction microscopy (STORM), an SMLM technique, offers a high spatial resolution for the position of the fluorophore. It is worth noting that large labels, for example, antibodies, can provide a misleading position of the fluorophore from the target molecule. However, the discovery and subsequent use of different SMLM techniques made it possible to accurately pinpoint the position of the fluorophore from the target molecule.

In principle, STED utilizes pairs of synchronized laser pulses, which play a critical role in overcoming the challenge of light diffraction. The basic functioning mechanism of this super-resolution microscopy technique is that it creates images through selective deactivation of fluorophores. This deactivation reduces the illumination area at the focal point and thus improves the achievable resolution for a specific system.

PET has also remarkably revolutionized the field of super resolution, particularly in biomedical research. This advanced imaging technique utilizes small amounts of radiotracers, a unique camera, and a computer to help in the evaluation of tissue and organ functions in patients. It is actually possible to detect early onset of diseases by identifying changes happening at the cellular level using PET.

Finally, cryo-EM is another super-resolution technique that is used to image frozen hydrated specimens at cryogenic temperatures. This imaging technique allows the specimens used in super-resolution studies to remain in their native state. Thus, this enables the study of fine cellular structures, protein complexes, and viruses at molecular resolution.

4. Aptamers for Super-Resolution Imaging

The enhanced imaging precision that resulted from the development of the previously discussed imaging techniques has also revealed that traditional staining using large affinity tags, for example, antibodies, are not sufficiently accurate. It is argued that since aptamers are significantly smaller than antibodies, these molecules might provide a practical advantage in super-resolution imaging.

In their study, de Castro et al. particularly compared the live staining of transferrin receptors acquired with varied fluorescently labelled affinity probes, including the natural receptor ligand transferrin, specific monoclonal antibodies, or aptamers. Analysis of the collected data showed that there were insignificant variations between the three mentioned staining strategies when imaging is carried out with traditional laser scanning confocal microscopy. Nevertheless, the aptamer tag showed clear superiority over antibodies in the super-resolved images acquired with STED microscopy. Thus it was concluded that compared to the natural receptor ligand transferrin and specific monoclonal antibodies, aptamer staining is ideal in super-resolution microscopy. It is worth noting that similar observations were reported when aptamers were compared to antibodies targeting different epitopes including prostate-specific membrane antigen and EGFR.

In another study that targeted three membrane receptors that are relevant to human health and cycle between the intracellular space and the plasma membrane, de Castro et al. observed that, compared to the majority of antibodies, aptamers were capable of revealing more epitopes and thus, offered denser labelling of stained structures, which enhanced the quality of the information obtained from the images. In this study aptamer labelling was advantageous under both super-resolution imaging and light microscopy imaging.

EGFR aptamer labelling also achieved a better quality in dSTORM imaging. In a recent study, aptamer labelling achieved detailed and precise structural analysis of the active EGFR that forms large clusters compared to EGFR at rest. This active-to-rest EGFR structure difference has not been detected using traditional antibodies. The ability of aptamers to detect small structural changes makes them promising candidates for studying the morphological changes occur for the membrane proteins during different biological activities.

Additionally, in vivo PET scanning of BT474 mice showed higher uptake of 18F-labelled aptamers that specifically bind to breast cancer expressing HER2. The confocal images also confirmed the specificity of 18F-labelled aptamers to HER2-positive cells. For strategies employed in the development of aptamer-based SPECT and PET imaging we refer the readers to an informative review by Hassanzadeh et al..

Aptamers are particularly appropriate structure-changing molecules that are capable of combining highly selective biorecognition as well as signal transduction. It is possible to select aptamers towards nearly any ligand molecules through SELEX and can readily be incorporated into the functional devices that boost new applications that range from DNA-machines in sensors to the bioseparations. It has been reported that binding of ligands often affects the stability of the nucleotides that the ligand directly contacts. Ligand binding also causes distal rearrangements in the structure of aptamers. These structural changes can easily be observed by evaluating the cleavage patterns using cryo-EM. Aptamer-based labelling need to be done before the freezing step. In their study, Stanlis et al. showed that ssDNA aptamers could be a useful tool for achieving accurate localization of specific proteins, under freeze-substitution fixation conditions, during studying the cellular fine structures using cryo-EM. They indicated that aptamers are sufficiently soluble probes to be used along with the organic solvents used in freeze-substitution conditions; however, it failed to achieve high-affinity binding.

Apart from possessing unique physical properties that make them superior to the conventional antibodies in super-resolution imaging, there are several particular modifications that allow aptamers to achieve the highest possible resolution. Choosing an acceptable photostable probe is one of the key features dictating the super-resolution imaging quality. Using stable tagged-aptamer-based probes in super-resolution microscopy allows obtaining favourable signal-to-noise ratio and also localizing the probes to specific targets without being degraded by the cellular machinery. One particular approach to achieve acceptable aptamer stability is the use of Spiegelmer technology. For example, instead of endonuclease-sensitive RNA aptamers (D-form), researchers select endonuclease-resistant RNA aptamers (L-form) that result from binding to the mirror-image of the intended target molecule. The mirror-image aptamer (L-form) subsequently is expected to bind the natural target molecule. Additionally, the substitution of the natural D-ribose with L-ribose renders the mirror-image aptamer completely stable. Another strategy that can be used to enable aptamers to achieve better resolution is to optimize the density of the target molecule and similarly the concentration of the library, that would increase the signal (target-aptamer interaction)-to-noise (interfering species) ratio.

The discovery of aptamers presents an opportunity for biomedical researchers to develop novel molecular targeting probes and effective diagnostic/treatment tools for different diseases. Undoubtedly as well, these molecules are promising tools for super-resolution microscopy and have already been shown superior to conventional antibodies in some applications.

References 179

  1. 1.
    Aptamers: Problems, Solutions and Prospects · 2013
    No notice
  2. 2.

    Saenger W. Principles of Nucleic acid Structure. 2013;1-8.

    Not in our library

  3. 3.

    Yarus M. Getting past the rna world: The initial darwinian ancestor. Cold Spring Harb. Perspect. Biol. 2011;3:a003590.

    Not in our library10.1101/cshperspect.a003590

  4. 4.

    Robertson M.P., Joyce G.F. The origins of the RNA world. Cold Spring Harb. Perspect. Biol. 2012;4:a003608.

    Not in our library10.1101/cshperspect.a003608

  5. 5.

    Higgs P.G., Lehman N. The RNA world: Molecular cooperation at the origins of life. Nat. Rev. Genet. 2015;16:7-17.

    Not in our library10.1038/nrg3841

  6. 6.

    Blumenstiel J.P. Evolutionary dynamics of transposable elements in a small RNA world. Trends Genet. 2011;27:23-31.

    Not in our library10.1016/j.tig.2010.10.003

  7. 7.

    Ulrich H., Wrenger C. Disease-specific biomarker discovery by aptamers. Cytom. Part A. 2009;75:727-733.

    Not in our library10.1002/cyto.a.20766

  8. 8.

    Tucker W.O. Towards Specific DNA Aptamers which Bind and Inhibit wwp1 Hect Ubiquitin Ligase in the Osteoblast. Ph.D. Thesis. 2013.

    Not in our library

  9. 9.

    Klussmann S. The Aptamer Handbook: Functional Oligonucleotides and Their Applications. 2006.

    Not in our library

  10. 10.

    Veedu R.N. Aptamers: Tools for Nanotherapy and Molecular Imaging. 2017.

    Not in our library

  11. 11.

    Kaur H., Bruno J.G., Kumar A., Sharma T.K. Aptamers in the therapeutics and diagnostics pipelines. Theranostics. 2018;8:4016-4032.

    Not in our library10.7150/thno.25958

  12. 12.

    Kaur H., Yung L.Y. Probing high affinity sequences of DNA aptamer against vegf165. PLoS ONE. 2012;7:e31196.

    Not in our library10.1371/journal.pone.0031196

  13. 13.

    Tuerk C., Gold L. Systematic evolution of ligands by exponential enrichment: RNA ligands to bacteriophage t4 DNA polymerase. Science. 1990;249:505-510.

    Not in our library10.1126/science.2200121

  14. 14.

    Gold L., Janjic N., Jarvis T., Schneider D., Walker J.J., Wilcox S.K., Zichi D. Aptamers and the RNA world, past and present. Cold Spring Harb. Perspect. Biol. 2012;4:a003582.

    Not in our library10.1101/cshperspect.a003582

  15. 15.

    Ellington A.D., Szostak J.W. In vitro selection of RNA molecules that bind specific ligands. Nature. 1990;346:818.

    Not in our library10.1038/346818a0

  16. 16.
    CELL-SELEX: Novel Perspectives of Aptamer-Based Therapeutics · 2008
    No notice
  17. 17.

    Gao H., Qian J., Yang Z., Pang Z., Xi Z., Cao S., Wang Y., Pan S., Zhang S., Wang W. Whole-cell selex aptamer-functionalised poly (ethyleneglycol)-poly (ε-caprolactone) nanoparticles for enhanced targeted glioblastoma therapy. Biomaterials. 2012;33:6264-6272.

    Not in our library10.1016/j.biomaterials.2012.05.020

  18. 18.

    Chen J., Tong T., Wang H. Super-resolution imaging in glycoscience: New developments and challenges. J. Innov. Opt. Health Sci. 2016;09:1630007.

    Not in our library10.1142/s179354581630007x

  19. 19.

    Sefah K., Shangguan D., Xiong X., O’donoghue M.B., Tan W. Development of DNA aptamers using cell-selex. Nat. Protoc. 2010;5:1169-1185.

    Not in our library10.1038/nprot.2010.66

  20. 20.

    Kaur H. Recent developments in cell-selex technology for aptamer selection. Biochim. Biophys. Acta Gen. Subj. 2018;1862:2323-2329.

    Not in our library10.1016/j.bbagen.2018.07.029

  21. 21.

    Ellington A.D., Szostak J.W. Selection in vitro of single-stranded DNA molecules that fold into specific ligand-binding structures. Nature. 1992;355:850.

    Not in our library10.1038/355850a0

  22. 22.

    Berkhout B., Klaver B. In vivo selection of randomly mutated retroviral genomes. Nucleic Acids Res. 1993;21:5020-5024.

    Not in our library10.1093/nar/21.22.5020

  23. 23.

    Coulter L.R., Landree M.A., Cooper T.A. Identification of a new class of exonic splicing enhancers by in vivo selection. Mol. Cell. Biol. 1997;17:2143-2150.

    Not in our library10.1128/mcb.17.4.2143

  24. 24.

    Jenison R.D., Gill S.C., Pardi A., Polisky B. High-resolution molecular discrimination by RNA. Science. 1994;263:1425-1429.

    Not in our library10.1126/science.7510417

  25. 25.

    Dobbelstein M., Shenk T. In vitro selection of RNA ligands for the ribosomal l22 protein associated with epstein-barr virus-expressed RNA by using randomized and cdna-derived RNA libraries. J. Virol. 1995;69:8027-8034.

    Not in our library10.1128/jvi.69.12.8027-8034.1995

  26. 26.

    Smith D., Kirschenheuter G.P., Charlton J., Guidot D.M., Repine J.E. In vitro selection of RNA-based irreversible inhibitors of human neutrophil elastase. Chem. Biol. 1995;2:741-750.

    Not in our library10.1016/1074-5521(95)90102-7

  27. 27.

    Jensen K.B., Atkinson B.L., Willis M.C., Koch T.H., Gold L. Using in vitro selection to direct the covalent attachment of human immunodeficiency virus type 1 rev protein to high-affinity RNA ligands. Proc. Natl. Acad. Sci. USA. 1995;92:12220-12224.

    Not in our library10.1073/pnas.92.26.12220

  28. 28.

    Golden M.C., Collins B.D., Willis M.C., Koch T.H. Diagnostic potential of photoselex-evolved ssdna aptamers. J. Biotechnol. 2000;81:167-178.

    Not in our library10.1016/s0168-1656(00)00290-x

  29. 29.

    Klußmann S., Nolte A., Bald R., Erdmann V.A., Fürste J.P. Mirror-image RNA that binds d-adenosine. Nat. Biotechnol. 1996;14:1112.

    Not in our library10.1038/nbt0996-1112

  30. 30.

    Bruno J.G. In vitroselection of DNA to chloroaromatics using magnetic microbead-based affinity separation and fluorescence detection. Biochem. Biophys. Res. Commun. 1997;234:117-120.

    Not in our library10.1006/bbrc.1997.6517

  31. 31.

    Tsai R.Y., Reed R.R. Identification of DNA recognition sequences and protein interaction domains of the multiple-zn-finger protein roaz. Mol. Cell. Biol. 1998;18:6447-6456.

    Not in our library10.1128/mcb.18.11.6447

  32. 32.

    Vant-Hull B., Payano-Baez A., Davis R.H., Gold L. The mathematics of selex against complex targets1. J. Mol. Biol. 1998;278:579-597.

    Not in our library10.1006/jmbi.1998.1727

  33. 33.
    High affinity ligands from in vitro selection: Complex targets · 1998
    Not checked
  34. 34.

    Homann M., Göringer H.U. Combinatorial selection of high affinity RNA ligands to live african trypanosomes. Nucleic Acids Res. 1999;27:2006-2014.

    Not in our library10.1093/nar/27.9.2006

  35. 35.

    Burke D.H., Willis J.H. Recombination, RNA evolution, and bifunctional RNA molecules isolated through chimeric selex. RNA. 1998;4:1165-1175.

    Not in our library10.1017/s1355838298980542

  36. 36.

    Wu L., Curran J.F. An allosteric synthetic DNA. Nucleic Acids Res. 1999;27:1512-1516.

    Not in our library10.1093/nar/27.6.1512

  37. 37.

    Kawakami J., Imanaka H., Yokota Y., Sugimoto N. In vitro selection of aptamers that act with Zn2+. J. Inorg. Biochem. 2000;82:197-206.

    Not in our library10.1016/s0162-0134(00)00158-6

  38. 38.

    White R., Rusconi C., Scardino E., Wolberg A., Lawson J., Hoffman M., Sullenger B. Generation of species cross-reactive aptamers using “toggle” selex. Mol. Ther. 2001;4:567-573.

    Not in our library10.1006/mthe.2001.0495

  39. 39.

    Pagratis N., Gold L., Shtatland T., Javornik B. Truncation selex method. U.S. Patent. 2001.

    Not in our library

  40. 40.

    Wen J.-D., Gray D.M. Selection of genomic sequences that bind tightly to ff gene 5 protein: Primer-free genomic selex. Nucleic Acids Res. 2004;32:e182.

    Not in our library10.1093/nar/gnh179

  41. 41.

    Pan W., Xin P., Clawson G.A. Minimal primer and primer-free selex protocols for selection of aptamers from random DNA libraries. BioTechniques. 2008;44:351-362.

    Not in our library10.2144/000112689

  42. 42.

    Pan W., Clawson G.A. Primer-free aptamer selection using a random DNA library. RNA Therapeutics. 2010;367-383.

    Not in our library

  43. 43.

    Martell R.E., Nevins J.R., Sullenger B.A. Optimizing aptamer activity for gene therapy applications using expression cassette selex. Mol. Ther. 2002;6:30-34.

    Not in our library10.1006/mthe.2002.0624

  44. 44.

    Berezovski M., Krylov S.N. Nonequilibrium capillary electrophoresis of equilibrium mixtures− a single experiment reveals equilibrium and kinetic parameters of protein− DNA interactions. J. Am. Chem. Soc. 2002;124:13674-13675.

    Not in our library10.1021/ja028212e

  45. 45.

    Wang C., Zhang M., Yang G., Zhang D., Ding H., Wang H., Fan M., Shen B., Shao N. Single-stranded DNA aptamers that bind differentiated but not parental cells: Subtractive systematic evolution of ligands by exponential enrichment. J. Biotechnol. 2003;102:15-22.

    Not in our library10.1016/s0168-1656(02)00360-7

  46. 46.

    Vater A., Jarosch F., Buchner K., Klussmann S. Short bioactive spiegelmers to migraine-associated calcitonin gene-related peptide rapidly identified by a novel approach: Tailored-selex. Nucleic Acids Res. 2003;31:e130.

    Not in our library10.1093/nar/gng130

  47. 47.

    Mendonsa S.D., Bowser M.T. In vitro evolution of functional DNA using capillary electrophoresis. J. Am. Chem. Soc. 2004;126:20-21.

    Not in our library10.1021/ja037832s

  48. 48.

    Okhonin V., Berezovski M., Krylov S.N. Sweeping capillary electrophoresis: A non-stopped-flow method for measuring bimolecular rate constant of complex formation between protein and DNA. J. Am. Chem. Soc. 2004;126:7166-7167.

    Not in our library10.1021/ja0481124

  49. 49.

    Asai R., Nishimura S.I., Aita T., Takahashi K. In vitro selection of DNA aptamers on chips using a method for generating point mutations. Anal. Lett. 2004;37:645-656.

    Not in our library10.1081/al-120029741

  50. 50.

    Drabovich A., Berezovski M., Krylov S.N. Selection of smart aptamers by equilibrium capillary electrophoresis of equilibrium mixtures (eceem). J. Am. Chem. Soc. 2005;127:11224-11225.

    Not in our library10.1021/ja0530016

  51. 51.

    Stoltenburg R., Reinemann C., Strehlitz B. Flumag-selex as an advantageous method for DNA aptamer selection. Anal. Bioanal. Chem. 2005;383:83-91.

    Not in our library10.1007/s00216-005-3388-9

  52. 52.

    Berezovski M.V., Musheev M.U., Drabovich A.P., Jitkova J.V., Krylov S.N. Non-selex: Selection of aptamers without intermediate amplification of candidate oligonucleotides. Nat. Protoc. 2006;1:1359.

    Not in our library10.1038/nprot.2006.200

  53. 53.

    Win M.N., Klein J.S., Smolke C.D. Codeine-binding RNA aptamers and rapid determination of their binding constants using a direct coupling surface plasmon resonance assay. Nucleic Acids Res. 2006;34:5670-5682.

    Not in our library10.1093/nar/gkl718

  54. 54.

    Khati M., Schüman M., Ibrahim J., Sattentau Q., Gordon S., James W. Neutralization of infectivity of diverse r5 clinical isolates of human immunodeficiency virus type 1 by gp120-binding 2′ f-RNA aptamers. J. Virol. 2003;77:12692-12698.

    Not in our library10.1128/jvi.77.23.12692-12698.2003

  55. 55.

    Ohuchi S.P., Ohtsu T., Nakamura Y. Selection of RNA aptamers against recombinant transforming growth factor-β type iii receptor displayed on cell surface. Biochimie. 2006;88:897-904.

    Not in our library10.1016/j.biochi.2006.02.004

  56. 56.

    Lorenz C., Gesell T., Zimmermann B., Schoeberl U., Bilusic I., Rajkowitsch L., Waldsich C., Von Haeseler A., Schroeder R. Genomic selex for hfq-binding RNAs identifies genomic aptamers predominantly in antisense transcripts. Nucleic Acids Res. 2010;38:3794-3808.

    Not in our library10.1093/nar/gkq032

  57. 57.

    Fujimoto Y., Nakamura Y., Ohuchi S. Hexim1-binding elements on mRNAs identified through transcriptomic selex and computational screening. Biochimie. 2012;94:1900-1909.

    Not in our library10.1016/j.biochi.2012.05.003

  58. 58.

    Layzer J.M., Sullenger B.A. Simultaneous generation of aptamers to multiple gamma-carboxyglutamic acid proteins from a focused aptamer library using deselex and convergent selection. Oligonucleotides. 2007;17:1-11.

    Not in our library10.1089/oli.2006.0059

  59. 59.

    Nitsche A., Kurth A., Dunkhorst A., Pänke O., Sielaff H., Junge W., Muth D., Scheller F., Stöcklein W., Dahmen C. One-step selection of vaccinia virus-binding DNA aptamers by monolex. BMC Biotechnol. 2007;7:48.

    Not in our library10.1186/1472-6750-7-48

  60. 60.

    Peng L., Stephens B.J., Bonin K., Cubicciotti R., Guthold M. A combined atomic force/fluorescence microscopy technique to select aptamers in a single cycle from a small pool of random oligonucleotides. Microsc. Res. Tech. 2007;70:372-381.

    Not in our library10.1002/jemt.20421

  61. 61.

    Fan M., McBurnett S.R., Andrews C.J., Allman A.M., Bruno J.G., Kiel J.L. Aptamer selection express: A novel method for rapid single-step selection and sensing of aptamers. J. Biomol. Tech. JBT. 2008;19:311.

    Not in our library

  62. 62.

    Raddatz M.S.L., Dolf A., Endl E., Knolle P., Famulok M., Mayer G. Enrichment of cell-targeting and population-specific aptamers by fluorescence-activated cell sorting. Angew. Chem. 2008;120:5268-5271.

    Not in our library10.1002/ange.200800216

  63. 63.

    Mayer G., Ahmed M.-S.L., Dolf A., Endl E., Knolle P.A., Famulok M. Fluorescence-activated cell sorting for aptamer selex with cell mixtures. Nat. Protoc. 2010;5:1993.

    Not in our library10.1038/nprot.2010.163

  64. 64.

    Tok J.B.-H., Fischer N.O. Single microbead selex for efficient ssdna aptamer generation against botulinum neurotoxin. Chem. Commun. 2008;1883-1885.

    Not in our library10.1039/b717936g

  65. 65.

    Knight C.G., Platt M., Rowe W., Wedge D.C., Khan F., Day P.J., McShea A., Knowles J., Kell D.B. Array-based evolution of DNA aptamers allows modelling of an explicit sequence-fitness landscape. Nucleic Acids Res. 2008;37:e6.

    Not in our library10.1093/nar/gkn899

  66. 66.

    Chushak Y., Stone M.O. In silico selection of RNA aptamers. Nucleic Acids Res. 2009;37:e87.

    Not in our library10.1093/nar/gkp408

  67. 67.

    Li S., Xu H., Ding H., Huang Y., Cao X., Yang G., Li J., Xie Z., Meng Y., Li X. Identification of an aptamer targeting hnrnp a1 by tissue slide-based selex. J. Pathol. 2009;218:327-336.

    Not in our library10.1002/path.2543

  68. 68.

    Park S.-m., Ahn J.-Y., Jo M., Lee D.-k., Lis J.T., Craighead H.G., Kim S. Selection and elution of aptamers using nanoporous sol-gel arrays with integrated microheaters. Lab Chip. 2009;9:1206-1212.

    Not in our library10.1039/b814993c

  69. 69.

    Zykovich A., Korf I., Segal D.J. Bind-n-seq: High-throughput analysis of in vitro protein–DNA interactions using massively parallel sequencing. Nucleic Acids Res. 2009;37:e151.

    Not in our library10.1093/nar/gkp802

  70. 70.

    Jolma A., Kivioja T., Toivonen J., Cheng L., Wei G., Enge M., Taipale M., Vaquerizas J.M., Yan J., Sillanpää M.J. Multiplexed massively parallel selex for characterization of human transcription factor binding specificities. Genome Res. 2010;20:861-873.

    Not in our library10.1101/gr.100552.109

  71. 71.

    Slattery M., Riley T., Liu P., Abe N., Gomez-Alcala P., Dror I., Zhou T., Rohs R., Honig B., Bussemaker H.J. Cofactor binding evokes latent differences in DNA binding specificity between hox proteins. Cell. 2011;147:1270-1282.

    Not in our library10.1016/j.cell.2011.10.053

  72. 72.

    Lou X., Qian J., Xiao Y., Viel L., Gerdon A.E., Lagally E.T., Atzberger P., Tarasow T.M., Heeger A.J., Soh H.T. Micromagnetic selection of aptamers in microfluidic channels. Proc. Natl. Acad. Sci. USA. 2009;106:2989-2994.

    Not in our library10.1073/pnas.0813135106

  73. 73.

    Qian J., Lou X., Zhang Y., Xiao Y., Soh H.T. Generation of highly specific aptamers via micromagnetic selection. Anal. Chem. 2009;81:5490-5495.

    Not in our library10.1021/ac900759k

  74. 74.

    Oh S.S., Qian J., Lou X., Zhang Y., Xiao Y., Soh H.T. Generation of highly specific aptamers via micromagnetic selection. Anal. Chem. 2011;83:1866.

    Not in our library10.1021/ac200033t

  75. 75.

    Huang C.-J., Lin H.-I., Shiesh S.-C., Lee G.-B. Integrated microfluidic system for rapid screening of crp aptamers utilizing systematic evolution of ligands by exponential enrichment (selex). Biosens. Bioelectron. 2010;25:1761-1766.

    Not in our library10.1016/j.bios.2009.12.029

  76. 76.

    Cho M., Xiao Y., Nie J., Stewart R., Csordas A.T., Oh S.S., Thomson J.A., Soh H.T. Quantitative selection of DNA aptamers through microfluidic selection and high-throughput sequencing. Proc. Natl. Acad. Sci. USA. 2010;107:15373-15378.

    Not in our library10.1073/pnas.1009331107

  77. 77.

    Mi J., Liu Y., Rabbani Z.N., Yang Z., Urban J.H., Sullenger B.A., Clary B.M. In vivo selection of tumor-targeting RNA motifs. Nat. Chem. Biol. 2010;6:22.

    Not in our library10.1038/nchembio.277

  78. 78.
    Aptamer-Based Multiplexed Proteomic Technology for Biomarker Discovery · 2010
    No notice
  79. 79.

    Savory N., Abe K., Sode K., Ikebukuro K. Selection of DNA aptamer against prostate specific antigen using a genetic algorithm and application to sensing. Biosens. Bioelectron. 2010;26:1386-1391.

    Not in our library10.1016/j.bios.2010.07.057

  80. 80.

    Nonaka Y., Yoshida W., Abe K., Ferri S., Schulze H., Bachmann T.T., Ikebukuro K. Affinity improvement of a vegf aptamer by in silico maturation for a sensitive vegf-detection system. Anal. Chem. 2012;85:1132-1137.

    Not in our library10.1021/ac303023d

  81. 81.

    Savory N., Lednor D., Tsukakoshi K., Abe K., Yoshida W., Ferri S., Jones B.V., Ikebukuro K. In silico maturation of binding-specificity of DNA aptamers against proteus mirabilis. Biotechnol. Bioeng. 2013;110:2573-2580.

    Not in our library10.1002/bit.24922

  82. 82.

    Savory N., Takahashi Y., Tsukakoshi K., Hasegawa H., Takase M., Abe K., Yoshida W., Ferri S., Kumazawa S., Sode K. Simultaneous improvement of specificity and affinity of aptamers against streptococcus mutans by in silico maturation for biosensor development. Biotechnol. Bioeng. 2014;111:454-461.

    Not in our library10.1002/bit.25111

  83. 83.

    Jing M., Bowser M.T. Isolation of DNA aptamers using micro free flow electrophoresis. Lab Chip. 2011;11:3703-3709.

    Not in our library10.1039/c1lc20461k

  84. 84.

    Hoon S., Zhou B., Janda K.D., Brenner S., Scolnick J. Aptamer selection by high-throughput sequencing and informatic analysis. Biotechniques. 2011;51:413-416.

    Not in our library10.2144/000113786

  85. 85.
    Rapid one-step selection method for generating nucleic acid aptamers: development of a DNA aptamer against α-bungarotoxin. · 2012
    Not checked
  86. 86.

    Thiel W.H., Bair T., Peek A.S., Liu X., Dassie J., Stockdale K.R., Behlke M.A., Miller Jr F.J., Giangrande P.H. Rapid identification of cell-specific, internalizing RNA aptamers with bioinformatics analyses of a cell-based aptamer selection. PLoS ONE. 2012;7:e43836.

    Not in our library10.1371/journal.pone.0043836

  87. 87.
    Capture-SELEX: Selection of DNA Aptamers for Aminoglycoside Antibiotics · 2012
    No notice
  88. 88.

    Waybrant B., Pearce T.R., Wang P., Sreevatsan S., Kokkoli E. Development and characterization of an aptamer binding ligand of fractalkine using domain targeted selex. Chem. Commun. 2012;48:10043-10045.

    Not in our library10.1039/c2cc34217k

  89. 89.

    WooáKim D., BockáGu M. Immobilization-free screening of aptamers assisted by graphene oxide. Chem. Commun. 2012;48:2071-2073.

    Not in our library10.1039/c2cc16473f

  90. 90.

    Gong Q., Wang J., Ahmad K.M., Csordas A.T., Zhou J., Nie J., Stewart R., Thomson J.A., Rossi J.J., Soh H.T. Selection strategy to generate aptamer pairs that bind to distinct sites on protein targets. Anal. Chem. 2012;84:5365-5371.

    Not in our library10.1021/ac300873p

  91. 91.
    RAPID-SELEX for RNA aptamers. · 2013
    Not checked
  92. 92.

    Kimoto M., Yamashige R., Matsunaga K.-i., Yokoyama S., Hirao I. Generation of high-affinity DNA aptamers using an expanded genetic alphabet. Nat. Biotechnol. 2013;31:453.

    Not in our library10.1038/nbt.2556

  93. 93.

    Sefah K., Yang Z., Bradley K.M., Hoshika S., Jiménez E., Zhang L., Zhu G., Shanker S., Yu F., Turek D. In vitro selection with artificial expanded genetic information systems. Proc. Natl. Acad. Sci. USA. 2014;111:1449-1454.

    Not in our library10.1073/pnas.1311778111

  94. 94.

    Lao Y.-H., Chiang H.-Y., Yang D.-K., Peck K., Chen L.-C. Selection of aptamers targeting the sialic acid receptor of hemagglutinin by epitope-specific selex. Chem. Commun. 2014;50:8719-8722.

    Not in our library10.1039/c4cc03116d

  95. 95.

    Lai J.-C., Hong C.-Y. Magnetic-assisted rapid aptamer selection (maras) for generating high-affinity DNA aptamer using rotating magnetic fields. ACS Comb. Sci. 2014;16:321-327.

    Not in our library10.1021/co5000272

  96. 96.

    Wang J., Gong Q., Maheshwari N., Eisenstein M., Arcila M.L., Kosik K.S., Soh H.T. Particle display: A quantitative screening method for generating high-affinity aptamers. Angew. Chem. Int. Ed. 2014;53:4796-4801.

    Not in our library10.1002/anie.201309334

  97. 97.

    Zhu Z., Song Y., Li C., Zou Y., Zhu L., An Y., Yang C.J. Monoclonal surface display selex for simple, rapid, efficient, and cost-effective aptamer enrichment and identification. Anal. Chem. 2014;86:5881-5888.

    Not in our library10.1021/ac501423g

  98. 98.

    Jacoby K., Scharenberg A.M. Homing endonuclease target determination using selex adapted for yeast surface display. Homing Endonucleases. 2014;165-190.

    Not in our library10.1007/978-1-62703-968-0_13

  99. 99.

    Ouellet E., Foley J.H., Conway E.M., Haynes C. Hi-fi selex: A high-fidelity digital-PCR based therapeutic aptamer discovery platform. Biotechnol. Bioeng. 2015;112:1506-1522.

    Not in our library10.1002/bit.25581

  100. 100.

    Mayer G., Tolle F. Method of identifying or producing an aptamer. Google Patents. 2017.

    Not in our library

  101. 101.

    Tolle F., Brändle G.M., Matzner D., Mayer G. A versatile approach towards nucleobase-modified aptamers. Angew. Chem. Int. Ed. 2015;54:10971-10974.

    Not in our library10.1002/anie.201503652

  102. 102.

    Takahashi M., Sakota E., Nakamura Y. The efficient cell-selex strategy, icell-selex, using isogenic cell lines for selection and counter-selection to generate RNA aptamers to cell surface proteins. Biochimie. 2016;131:77-84.

    Not in our library10.1016/j.biochi.2016.09.018

  103. 103.

    Zumrut H.E., Ara M.N., Fraile M., Maio G., Mallikaratchy P. Ligand-guided selection of target-specific aptamers: A screening technology for identifying specific aptamers against cell-surface proteins. Nucleic Acid Ther. 2016;26:190-198.

    Not in our library10.1089/nat.2016.0611

  104. 104.

    Yu H., Yang W., Alkhamis O., Canoura J., Yang K., Xiao Y. In vitro isolation of small-molecule-binding aptamers with intrinsic dye-displacement functionality. Nucleic Acids Res. 2018.

    Not in our library10.1093/nar/gky026

  105. 105.

    Damase T.R., Miura T.A., Parent C.E., Allen P.B. Application of the open qPCR instrument for the in vitro selection of DNA aptamers against epidermal growth factor receptor and drosophila c virus. ACS Comb. Sci. 2018.

    Not in our library10.1021/acscombsci.7b00138

  106. 106.

    Kulbachinskiy A. Methods for selection of aptamers to protein targets. Biochemistry. 2007;72:1505-1518.

    Not in our library10.1134/s000629790713007x

  107. 107.

    Greenleaf W.J., Frieda K.L., Foster D.A., Woodside M.T., Block S.M. Direct observation of hierarchical folding in single riboswitch aptamers. Science. 2008;319:630-633.

    Not in our library10.1126/science.1151298

  108. 108.

    Gu M.B., Kim H.-S. Biosensors Based on Aptamers and Enzymes. 2014;Volume 140.

    Not in our library

  109. 109.

    Huang B., Wang W., Bates M., Zhuang X. Three-dimensional super-resolution imaging by stochastic optical reconstruction microscopy. Science. 2008;319:810-813.

    Not in our library10.1126/science.1153529

  110. 110.

    Lippincott-Schwartz J., Patterson G.H. Photoactivatable fluorescent proteins for diffraction-limited and super-resolution imaging. Trends Cell Biol. 2009;19:555-565.

    Not in our library10.1016/j.tcb.2009.09.003

  111. 111.

    Senoner M., Unger W.E. Sims imaging of the nanoworld: Applications in science and technology. J. Anal. At. Spectrom. 2012;27:1050-1068.

    Not in our library10.1039/c2ja30015j

  112. 112.

    Newman C.F., Havelund R., Passarelli M.K., Marshall P.S., Francis I., West A., Alexander M.R., Gilmore I.S., Dollery C.T. Intracellular drug uptake a comparison of single cell measurements using tof-sims imaging and quantification from cell populations with lc/ms/ms. Anal. Chem. 2017;89:11944-11953.

    Not in our library10.1021/acs.analchem.7b01436

  113. 113.

    Huang B., Babcock H., Zhuang X. Breaking the diffraction barrier: Super-resolution imaging of cells. Cell. 2010;143:1047-1058.

    Not in our library10.1016/j.cell.2010.12.002

  114. 114.

    Mairal T., Özalp V.C., Sánchez P.L., Mir M., Katakis I., O’Sullivan C.K. Aptamers: Molecular tools for analytical applications. Anal. Bioanal. Chem. 2008;390:989-1007.

    Not in our library10.1007/s00216-007-1346-4

  115. 115.

    Toh S.Y., Citartan M., Gopinath S.C., Tang T.-H. Aptamers as a replacement for antibodies in enzyme-linked immunosorbent assay. Biosens. Bioelectron. 2015;64:392-403.

    Not in our library10.1016/j.bios.2014.09.026

  116. 116.

    Chen A., Yang S. Replacing antibodies with aptamers in lateral flow immunoassay. Biosens. Bioelectron. 2015;71:230-242.

    Not in our library10.1016/j.bios.2015.04.041

  117. 117.

    Tan W., Wang H., Chen Y., Zhang X., Zhu H., Yang C., Yang R., Liu C. Molecular aptamers for drug delivery. Trends Biotechnol. 2011;29:634-640.

    Not in our library10.1016/j.tibtech.2011.06.009

  118. 118.

    Banerjee J., Nilsen-Hamilton M. Aptamers: Multifunctional molecules for biomedical research. J. Mol. Med. 2013;91:1333-1342.

    Not in our library10.1007/s00109-013-1085-2

  119. 119.

    Stoltenburg R., Reinemann C., Strehlitz B. Selex—a (r) evolutionary method to generate high-affinity nucleic acid ligands. Biomol. Eng. 2007;24:381-403.

    Not in our library10.1016/j.bioeng.2007.06.001

  120. 120.

    Fang X., Tan W. Aptamers generated from cell-selex for molecular medicine: A chemical biology approach. Acc. Chem. Res. 2009;43:48-57.

    Not in our library10.1021/ar900101s

  121. 121.

    Ruigrok V.J., Levisson M., Eppink M.H., Smidt H., Van Der Oost J. Alternative affinity tools: More attractive than antibodies? Biochem. J. 2011;436:1-13.

    Not in our library10.1042/bj20101860

  122. 122.

    Lee J.-O., So H.-M., Jeon E.-K., Chang H., Won K., Kim Y.H. Aptamers as molecular recognition elements for electrical nanobiosensors. Anal. Bioanal. Chem. 2008;390:1023-1032.

    Not in our library10.1007/s00216-007-1643-y

  123. 123.

    Kedzierski S., Khoshnejad M., Caltagirone G.T. Synthetic antibodies: The emerging field of aptamers. Bioprocess. J. 2012;11:46-49.

    Not in our library10.12665/j114.kedzierskicaltagirone

  124. 124.
    Challenges and Opportunities for Small Molecule Aptamer Development · 2012
    No notice
  125. 125.

    Que E.L., Domaille D.W., Chang C.J. Metals in neurobiology: Probing their chemistry and biology with molecular imaging. Chem. Rev. 2008;108:1517-1549.

    Not in our library10.1021/cr078203u

  126. 126.

    Keiser M.J., Setola V., Irwin J.J., Laggner C., Abbas A.I., Hufeisen S.J., Jensen N.H., Kuijer M.B., Matos R.C., Tran T.B. Predicting new molecular targets for known drugs. Nature. 2009;462:175-181.

    Not in our library10.1038/nature08506

  127. 127.

    Berezovski M.V., Lechmann M., Musheev M.U., Mak T.W., Krylov S.N. Aptamer-facilitated biomarker discovery (aptabid). J. Am. Chem. Soc. 2008;130:9137-9143.

    Not in our library10.1021/ja801951p

  128. 128.

    Kalani M.Y.S., Theodore N. Personalized medicine and neurosurgery. Front. Surg. 2017;4:19.

    Not in our library10.3389/fsurg.2017.00019

  129. 129.

    De Castro M.A.G., Höbartner C., Opazo F. Aptamers provide superior stainings of cellular receptors studied under super-resolution microscopy. PLoS ONE. 2017;12:e0173050.

    Not in our library10.1371/journal.pone.0173050

  130. 130.

    de Castro M.A., Rammner B., Opazo F. Aptamer stainings for super-resolution microscopy. Methods Mol. Biol. 2016;1380:197-210.

    Not in our library10.1007/978-1-4939-3197-2_17

  131. 131.

    Smolyaninov I.I., Hung Y.-J., Davis C.C. Magnifying superlens in the visible frequency range. Science. 2007;315:1699-1701.

    Not in our library10.1126/science.1138746

  132. 132.

    Xu K., Babcock H.P., Zhuang X. Dual-objective storm reveals three-dimensional filament organization in the actin cytoskeleton. Nat. Methods. 2012;9:185-188.

    Not in our library10.1038/nmeth.1841

  133. 133.

    Uhlén M. Affinity as a tool in life science. Biotechniques. 2008;44:649.

    Not in our library10.2144/000112803

  134. 134.

    Ries J., Kaplan C., Platonova E., Eghlidi H., Ewers H. A simple, versatile method for gfp-based super-resolution microscopy via nanobodies. Nat. Methods. 2012;9:582-584.

    Not in our library10.1038/nmeth.1991

  135. 135.
    Resolving bundled microtubules using anti-tubulin nanobodies · 2015
    No notice
  136. 136.

    Opazo F., Levy M., Byrom M., Schäfer C., Geisler C., Groemer T.W., Ellington A.D., Rizzoli S.O. Aptamers as potential tools for super-resolution microscopy. Nat. Methods. 2012;9:938.

    Not in our library10.1038/nmeth.2179

  137. 137.

    Ylera F., Lurz R., Erdmann V.A., Furste J.P. Selection of RNA aptamers to the alzheimer’s disease amyloid peptide. Biochem. Biophys. Res. Commun. 2002;290:1583-1588.

    Not in our library10.1006/bbrc.2002.6354

  138. 138.

    Rahimi F., Murakami K., Summers J.L., Chen C.H., Bitan G. RNA aptamers generated against oligomeric abeta40 recognize common amyloid aptatopes with low specificity but high sensitivity. PLoS ONE. 2009;4:e7694.

    Not in our library10.1371/journal.pone.0007694

  139. 139.

    Janas T., Sapon K., Stowell M.H.B., Janas T. Selection of membrane RNA aptamers to amyloid beta peptide: Implications for exosome-based antioxidant strategies. Int. J. Mol. Sci. 2019;20:299.

    Not in our library10.3390/ijms20020299

  140. 140.

    Mahmoud M., Deigner H.-P. Aptamers in diagnostics: Replacing or complementing antibodies? J. Biochips Tissue Chips. 2015;5:1.

    Not in our library10.4172/2153-0777.1000e129

  141. 141.

    Kanwar J.R., Roy K., Maremanda N.G., Subramanian K., Veedu R.N., Bawa R., Kanwar R.K. Nucleic acid-based aptamers: Applications, development and clinical trials. Curr. Med. Chem. 2015;22:2539-2557.

    Not in our library10.2174/0929867322666150227144909

  142. 142.
    Aptamer Therapeutics in Cancer: Current and Future · 2018
    No notice
  143. 143.

    Pereira R.L., Nascimento I.C., Santos A.P., Ogusuku I.E.Y., Lameu C., Mayer G., Ulrich H. Aptamers: Novelty tools for cancer biology. Oncotarget. 2018;9:26934-26953.

    Not in our library10.18632/oncotarget.25260

  144. 144.

    Hori S.I., Herrera A., Rossi J.J., Zhou J. Current advances in aptamers for cancer diagnosis and therapy. Cancers. 2018;10:9.

    Not in our library10.3390/cancers10010009

  145. 145.

    Hell S.W. Microscopy and its focal switch. Nat. Methods. 2009;6:24-32.

    Not in our library10.1038/nmeth.1291

  146. 146.

    Harke B., Keller J., Ullal C.K., Westphal V., Schönle A., Hell S.W. Resolution scaling in sted microscopy. Opt. Express. 2008;16:4154-4162.

    Not in our library10.1364/oe.16.004154

  147. 147.

    Chen W., Delaloye S., Silverman D.H., Geist C., Czernin J., Sayre J., Satyamurthy N., Pope W., Lai A., Phelps M.E. Predicting treatment response of malignant gliomas to bevacizumab and irinotecan by imaging proliferation with [18f] fluorothymidine positron emission tomography: A pilot study. J. Clin. Oncol. 2007;25:4714-4721.

    Not in our library10.1200/jco.2006.10.5825

  148. 148.

    Sartori A., Gatz R., Beck F., Rigort A., Baumeister W., Plitzko J.M. Correlative microscopy: Bridging the gap between fluorescence light microscopy and cryo-electron tomography. J. Struct. Biol. 2007;160:135-145.

    Not in our library10.1016/j.jsb.2007.07.011

  149. 149.

    Pavani S.R.P., Thompson M.A., Biteen J.S., Lord S.J., Liu N., Twieg R.J., Piestun R., Moerner W. Three-dimensional, single-molecule fluorescence imaging beyond the diffraction limit by using a double-helix point spread function. Proc. Natl. Acad. Sci. USA. 2009;106:2995-2999.

    Not in our library10.1073/pnas.0900245106

  150. 150.

    Holly T.A., Abbott B.G., Al-Mallah M., Calnon D.A., Cohen M.C., DiFilippo F.P., Ficaro E.P., Freeman M.R., Hendel R.C., Jain D. Single photon-emission computed tomography. J. Nucl. Cardiol. 2010;17:941-973.

    Not in our library10.1007/s12350-010-9246-y

  151. 151.

    Rego E.H., Shao L., Macklin J.J., Winoto L., Johansson G.A., Kamps-Hughes N., Davidson M.W., Gustafsson M.G. Nonlinear structured-illumination microscopy with a photoswitchable protein reveals cellular structures at 50-nm resolution. Proc. Natl. Acad. Sci. USA. 2012;109:E135-E143.

    Not in our library10.1073/pnas.1107547108

  152. 152.

    Rossy J., Cohen E., Gaus K., Owen D.M. Method for co-cluster analysis in multichannel single-molecule localisation data. Histochem. Cell Biol. 2014;141:605-612.

    Not in our library10.1007/s00418-014-1208-z

  153. 153.

    Vira S., Mekhedov E., Humphrey G., Blank P.S. Fluorescent-labeled antibodies: Balancing functionality and degree of labeling. Anal. Biochem. 2010;402:146-150.

    Not in our library10.1016/j.ab.2010.03.036

  154. 154.

    Bates M., Huang B., Dempsey G.T., Zhuang X. Multicolor super-resolution imaging with photo-switchable fluorescent probes. Science. 2007;317:1749-1753.

    Not in our library10.1126/science.1146598

  155. 155.

    Heilemann M., Van De Linde S., Schüttpelz M., Kasper R., Seefeldt B., Mukherjee A., Tinnefeld P., Sauer M. Subdiffraction-resolution fluorescence imaging with conventional fluorescent probes. Angew. Chem. Int. Ed. 2008;47:6172-6176.

    Not in our library10.1002/anie.200802376

  156. 156.

    Granov A., Tiutin L., Schwarz T. Positron Emission Tomography. 2013.

    Not in our library

  157. 157.

    Zwan M.D., Bouwman F.H., Konijnenberg E., van der Flier W.M., Lammertsma A.A., Verhey F.R., Aalten P., van Berckel B.N., Scheltens P. Diagnostic impact of [18F] flutemetamol pet in early-onset dementia. Alzheimers Res. 2017;9:2.

    Not in our library10.1186/s13195-016-0228-4

  158. 158.

    Marcus C., Mena E., Subramaniam R.M. Brain pet in the diagnosis of alzheimer’s disease. Clin. Nucl. Med. 2014;39:e413-e426.

    Not in our library10.1097/rlu.0000000000000547

  159. 159.

    Cohen A.D., Rabinovici G.D., Mathis C.A., Jagust W.J., Klunk W.E., Ikonomovic M.D. Using pittsburgh compound b for in vivo pet imaging of fibrillar amyloid-beta. Adv. Pharm. 2012;64:27-81.

    Not in our library10.1016/b978-0-12-394816-8.00002-7

  160. 160.

    Nickell S., Beck F., Korinek A., Mihalache O., Baumeister W., Plitzko J.M. Automated cryoelectron microscopy of “single particles” applied to the 26s proteasome. Febs Lett. 2007;581:2751-2756.

    Not in our library10.1016/j.febslet.2007.05.028

  161. 161.

    Oda T., Hirokawa N., Kikkawa M. Three-dimensional structures of the flagellar dynein–microtubule complex by cryoelectron microscopy. J. Cell Biol. 2007;177:243-252.

    Not in our library10.1083/jcb.200609038

  162. 162.

    Hoenger A. High-resolution cryo-electron microscopy on macromolecular complexes and cell organelles. Protoplasma. 2014;251:417-427.

    Not in our library10.1007/s00709-013-0600-1

  163. 163.

    Yan Q., Cai M., Zhou L., Xu H., Shi Y., Sun J., Jiang J., Gao J., Wang H. Using an RNA aptamer probe for super-resolution imaging of native egfr. Nanoscale Adv. 2019;1:291-298.

    Not in our library10.1039/c8na00143j

  164. 164.

    Fornasiero E.F., Opazo F. Super-resolution imaging for cell biologists. Bioessays. 2015;37:436-451.

    Not in our library10.1002/bies.201400170

  165. 165.

    Kim H.J., Park J.Y., Lee T.S., Song I.H., Cho Y.L., Chae J.R., Kang H., Lim J.H., Lee J.H., Kang W.J. Pet imaging of her2 expression with an 18f-fluoride labeled aptamer. PLoS ONE. 2019;14:e0211047.

    Not in our library10.1371/journal.pone.0211047

  166. 166.

    Hassanzadeh L., Chen S., Veedu R.N. Radiolabeling of nucleic acid aptamers for highly sensitive disease-specific molecular imaging. Pharmaceuticals. 2018;11:106.

    Not in our library10.3390/ph11040106

  167. 167.

    Serrano-Santos M.B., Llobet E., Özalp V.C., Schäfer T. Characterization of structural changes in aptamer films for controlled release nanodevices. Chem. Commun. 2012;48:10087-10089.

    Not in our library10.1039/c2cc35683j

  168. 168.

    Mayer G. The Chemical Biology of Nucleic Acids.

    Not in our library

  169. 169.

    Stanlis K.K., McIntosh J.R. Single-strand DNA aptamers as probes for protein localization in cells. J Histochem. Cytochem. 2003;51:797-808.

    Not in our library10.1177/002215540305100611

  170. 170.

    Schermelleh L., Heintzmann R., Leonhardt H. A guide to super-resolution fluorescence microscopy. J. Cell Biol. 2010;190:165-175.

    Not in our library10.1083/jcb.201002018

  171. 171.

    Dempsey G.T., Vaughan J.C., Chen K.H., Bates M., Zhuang X. Evaluation of fluorophores for optimal performance in localization-based super-resolution imaging. Nat. Methods. 2011;8:1027-1036.

    Not in our library10.1038/nmeth.1768

  172. 172.

    Lukinavicius G., Mitronova G.Y., Schnorrenberg S., Butkevich A.N., Barthel H., Belov V.N., Hell S.W. Fluorescent dyes and probes for super-resolution microscopy of microtubules and tracheoles in living cells and tissues. Chem. Sci. 2018;9:3324-3334.

    Not in our library10.1039/c7sc05334g

  173. 173.

    Kong H.Y., Byun J. Nucleic acid aptamers: New methods for selection, stabilization, and application in biomedical science. Biomol. Ther. 2013;21:423.

    Not in our library10.4062/biomolther.2013.085

  174. 174.
    New Technologies Provide Quantum Changes in the Scale, Speed, and Success of SELEX Methods and Aptamer Characterization · 2014
    Not checked
  175. 175.

    Cooper T.A. In Vivo Selex Strategies. Handbook of RNA Biochemistry: Second, Completely Revised and Enlarged Edition.

    Not in our library

  176. 176.

    Szeto K., Craighead H.G. Devices and approaches for generating specific high-affinity nucleic acid aptamers. Appl. Phys. Rev. 2014;1:031103.

    Not in our library10.1063/1.4894851

  177. 177.

    Tombelli S., Minunni M., Mascini M. Aptamers-based assays for diagnostics, environmental and food analysis. Biomol. Eng. 2007;24:191-200.

    Not in our library10.1016/j.bioeng.2007.03.003

  178. 178.

    White R.J., Phares N., Lubin A.A., Xiao Y., Plaxco K.W. Optimization of electrochemical aptamer-based sensors via optimization of probe packing density and surface chemistry. Langmuir. 2008;24:10513-10518.

    Not in our library10.1021/la800801v

  179. 179.

    Nair P.R., Alam M.A. Theory of "selectivity" of label-free nanobiosensors: A geometro-physical perspective. J. Appl. Phys. 2010;107:64701.

    Not in our library10.1063/1.3310531

Cited by papers we hold 2

Reads

Read by people on this page

None yet.

Checked or read by AI through naulon

None yet.

A person counts once a day per paper. We keep no cookie and no address: a reader is a hash that changes every day. Any month under five reads shows no number.

Are you an author?

Is this your paper?

Claim it to add your note and be paid when agents cite it. Free.